Rethinking Composite End Points in Clinical Trials: Insights From Patients and Trialists

BACKGROUND—Many clinical trials use composite end points to reduce sample size, but the relative importance of each individual end point within the composite may differ between patients and researchers. METHODS AND RESULTS—We asked 785 cardiovascular patients and 164 clinical trial authors to assign...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2014-10, Vol.130 (15), p.1254-1261
Hauptverfasser: Stolker, Joshua M, Spertus, John A, Cohen, David J, Jones, Philip G, Jain, Kaushik K, Bamberger, Emily, Lonergan, Brady B, Chan, Paul S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!